The Latest Breaking News from Moderna

The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.

Biotech giant Moderna's first mRNA vaccine facility in Australia is due to open in 2024, and will produce 100 million vaccine doses per year.

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

Kate Bingham raises concerns to committee of MPs as head of UKHSA suggests Covid could be on rise again

How scientists across Africa plan to use mRNA technology to fight diseases and tackle inequities in global health.

The US researchers have created a vaccine based on the same mRNA technology used in the Covid-19 jabs from Moderna and Pfizer.

An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.

Americans who have gotten the updated COVID-19 boosters appear better protected against symptomatic infection than those who haven't — at least for now

Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.

Pfizer said its updated COVID-19 booster may offer some protection against newly emerging omicron mutants even though it’s not an exact match

Pfizer and BioNTech said Thursday they've started testing a next-generation Covid shot, and both vaccine stocks reversed early declines.